Close Menu

NEW YORK (GenomeWeb) – Evotec announced today that it has signed agreements to incorporate a portfolio of genome-editing and gene silencing technologies from Merck KGaA's life science business, known as MilliporeSigma in the US and Canada, into its screening and disease model platforms for target discovery.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on the US National Science Foundation's investigations of undisclosed foreign ties among researchers it funds.

Researchers have developed a set of 10 principles to guide how a list of all species on earth should be put together, the Guardian reports.

Wired reports on a new firm developing a gene writing approach for therapeutic genome changes.

In Nature this week: a method called cis-X combines whole-genome and transcriptome sequencing data to identify regulatory noncoding variants, and more.